Welcome to our dedicated page for OTC Markets Group news (Ticker: OTCM), a resource for investors and traders seeking the latest updates and insights on OTC Markets Group stock.
OTC Markets Group Inc. (OTCQX: OTCM) provides essential infrastructure for trading 12,000+ U.S. and global securities through regulated markets and real-time financial data solutions. This page aggregates official announcements and verified news about the company's market operations, strategic partnerships, and regulatory developments.
Investors and financial professionals will find comprehensive updates covering OTCM's OTCQX/OTCQB market enhancements, alternative trading system innovations, and corporate services expansion. Key updates include earnings reports, technology integrations like Nasdaq Data Link partnerships, and operational milestones such as extended trading hour implementations.
All content undergoes strict verification to ensure alignment with financial disclosure standards. Bookmark this page for direct access to OTCM's latest market data product launches, compliance updates, and leadership insights that shape transparent trading ecosystems.
OTC Markets Group Inc. has welcomed CloudMD Software & Services Inc (OTCQX: DOCRF) to the OTCQX® Best Market, enhancing its trading profile for U.S. investors. This upgrade allows CloudMD to utilize its home market reporting for greater transparency and compliance with established financial standards. The company focuses on revolutionizing healthcare delivery through technology and a patient-centric approach, currently serving a vast network of healthcare professionals across North America.
Playmaker Capital Inc. (TSX-V: PMKR; OTCQX: PMKRF), a Toronto-based digital sports media company, has upgraded to the OTCQX® Best Market from the Pink® market. This transition allows for more transparent trading for U.S. investors seeking access to the company. Playmaker's CEO, Jordan Gnat, highlighted the opportunity for greater investor participation in their sports-focused initiatives. The upgrade reflects compliance with high financial standards and corporate governance, enhancing Playmaker's visibility and credibility in the U.S. market.
OTC Markets Group Inc. announced that Coinshares International Limited (OTCQX: CNSRF) has qualified to trade on the OTCQX® Best Market, moving up from the Pink® market. This upgrade aims to enhance transparency for U.S. investors. Starting today, Coinshares International Limited's stock is available for trading under the symbol CNSRF. The company's CEO emphasized that this milestone supports their strategy to increase shareholder value and broaden access to the digital asset ecosystem.
OTC Markets Group Inc. (OTCQX: OTCM) has launched an upgraded version of its Qaravan platform, enhancing analytics for bank executives and regulators. The platform now provides comprehensive data on bank holding companies as well as OTC market data, improving coverage across public and private banking entities. Key features include customizable news feeds, live stock quotes, and historical data on mergers and acquisitions. This upgrade aims to offer a more intuitive user experience, with data formats accessible on OTCMarkets.com, benefiting over 100 OTCQX-traded banks.
OTC Markets Group reported third quarter 2021 gross revenues of $25.2 million, marking a 42% increase from the previous year. Operating income rose 77% to $9.7 million, and net income increased 68% to $7.5 million, leading to a quarterly diluted GAAP EPS of $0.62. The company declared a special dividend of $1.50 per share and a quarterly dividend of $0.18. Significant growth was noted in OTCQX and OTCQB market issuers, with total cash returned to shareholders at $2.1 million.
OTC Markets Group Inc. announced that IronRidge Resources Limited has upgraded to trading on the OTCQX Best Market from the Pink Market, effective November 8, 2021. This upgrade allows IronRidge to provide transparent trading for U.S. investors. The company’s CEO, Vincent Mascolo, emphasized the importance of this platform in reaching a broader investor audience, especially after their agreement with Piedmont Lithium Inc. to fast-track the Ewoyaa Lithium Project. Investors can find financial disclosures and quotes for IRRLF on OTC Markets.
OTC Markets Group Inc. (OTCQX: OTCM) will announce its Q3 financial results on November 10, 2021, after U.S. market close. A conference call is scheduled for November 11, 2021, at 8:30 a.m. ET to discuss these results. Investors can join via a domestic dial-in number (1-877-665-5564) or an international number (1-470-495-9522). Replay options are available until November 25, 2021. The earnings release and related documents will be accessible in the Investor Relations section of the company's website.
OTC Markets Group Inc. announced that Goviex Uranium Inc. has upgraded to the OTCQX® Best Market, commencing trading under the symbol "GVXXF". This designation indicates that Goviex meets high financial standards and best corporate governance practices. CEO Daniel Major stated that this upgrade enhances the company's visibility and appeal to U.S. investors. Goviex focuses on uranium properties in Africa, with key projects including the Madaouela Project in Niger, the Mutanga Project in Zambia, and the Falea Project in Mali.
OTC Markets Group Inc. has welcomed Vibe Growth Corporation to the OTCQX Best Market, upgrading from the Pink market. Vibe Growth Corporation, a vertically integrated cannabis company, begins trading under the symbol VIBEF. The upgrade aims to enhance trading access for U.S. investors and aligns with the company’s growth strategy in the cannabis sector. Companies listed on OTCQX must meet high financial standards and follow corporate governance best practices. This move allows Vibe to reach more investors in the U.S. and Canada, tapping into the expanding California cannabis market.
OTC Markets Group Inc. announced that e-therapeutics plc has qualified to trade on the OTCQX Best Market under the symbol ETXPF. This upgrade allows U.S. investors access to buy and sell shares through online platforms. The move aims to broaden the company’s shareholder base and enhance transparency in trading. e-therapeutics specializes in computational drug discovery, focusing on RNAi therapeutics, utilizing advanced technologies such as machine learning and artificial intelligence in drug development.